Heart Disease News and Research

Latest Heart Disease News and Research

Genzyme third quarter revenue increases to $1.0 billion

Genzyme Corp. today reported third-quarter earnings growth driven by increased shipments of Cerezyme® (imiglucerase for injection). Patients in the United States began returning to normal dosing levels last month, and patients globally are expected to be able to do so this quarter. Earnings growth in the third quarter was also driven by strong revenue from Lumizyme™ (alglucosidase alfa) and cost reduction measures.

21 Oct 2010

Beaumont Hospital announces opening of new Ernst Cardiovascular Center

Beaumont Hospitals' world renowned heart center has expanded and enhanced its services with the Oct. 18 opening of the new Ernst Cardiovascular Center at Beaumont Hospital, Royal Oak.

21 Oct 2010

Z-Medica enters agreement with two Swedish medical device distributors for QuikClot products

Z-Medica Corporation, a medical device company developing innovative hemostatic agents, today announced that it has signed exclusive distribution agreements with Vingmed AB and Mediplast AB, two leading Swedish medical device distributors, for distribution of its QuikClot line of hemostatic agents in Sweden, Denmark and Norway for the first time.

From Medica Corporation 21 Oct 2010

Alexion announces results of eculizumab two open-label Phase 2 studies for aHUS treatment

Alexion Pharmaceuticals, Inc. today announced that its two open-label Phase 2 studies investigating eculizumab (Soliris) as a treatment for patients with atypical Hemolytic Uremic Syndrome (aHUS) have met the primary and key secondary endpoints with high clinical and statistical significance, in interim analyses.

21 Oct 2010

Genzyme reports results of Clolar combination Phase 3 trial in adult AML

Genzyme Corporation announced results today from its CLASSIC I phase 3 trial comparing Clolar® (clofarabine) in combination with the chemotherapy agent cytarabine (ara-c) to cytarabine plus placebo in relapsed-refractory adult acute myeloid leukemia (AML).

21 Oct 2010

FDA approves Herceptin with chemotherapy for HER2-positive metastatic cancer

Genentech, a member of the Roche Group today announced the U.S. Food and Drug Administration (FDA) has approved Herceptin (trastuzumab) in combination with chemotherapy (cisplatin plus either capecitabine or 5-fluorouracil [5-FU]) for HER2-positive metastatic (cancer that has spread) cancer of the stomach or gastroesophageal junction, in men and women who have not received prior medicines for their metastatic disease.

21 Oct 2010

NHS needs £20bn of efficiency savings

Britain’s NHS would become one of only two government departments not to face budget cuts in the latest spending review. However some key features have been removed. This includes one-week wait for cancer diagnosis and free prescriptions for people with long-term illnesses.

20 Oct 2010

Abbott third quarter worldwide sales increase 11.8% to $8.7 billion

Abbott today announced financial results for the third quarter ended Sept. 30, 2010.

20 Oct 2010

Pfizer enters partnership with Teuto to develop, commercialize generic medicines

Pfizer Inc. announced today that it is entering into a partnership with Laboratorio Teuto Brasileiro S.A., a leading company in the Brazilian generics industry, to develop and commercialize generic medicines.

20 Oct 2010

St. Jude Medical third quarter net sales increase 7% to $1.240 billion

St. Jude Medical, Inc. today reported sales and net earnings for the third quarter ended October 2, 2010.

20 Oct 2010

CRN reinforces importance of DHA before, during and after pregnancy

In response to a study regarding fish oil use during pregnancy published in the October 19 issue of the Journal of the American Medical Association (JAMA), the Council for Responsible Nutrition (CRN), the leading trade association for the dietary supplement industry, reminds pregnant and lactating women of the undisputed importance of consuming the recommended amounts of docosahexaenoic acid (DHA) throughout pregnancy.

20 Oct 2010

ACS NSQIP recognizes Christiana Care Health System as participating hospital

The American College of Surgeons National Surgical Quality Improvement Program (ACS NSQIP) has recognized Christiana Care Health System as one of 26 ACS NSQIP participating hospitals in the United States that have achieved exemplary outcomes for surgical patient care.

20 Oct 2010

PBS-Bio announces three new contracts to develop cancer therapy

In an industry that faces increasing challenges in delivering new drugs to patients, Predictive Biomarker Sciences (PBS-Bio) today announced three new contracts aimed at bringing new medicines to the marketplace.

20 Oct 2010

Study finds massive blood transfusion associated with severe complications

A study presented at this year's American Society of Anesthesiologists Annual Meeting indicates that massive blood transfusion is associated with a significant increase in perioperative risk for mortality, cardiopulmonary complications, and wound-related and infectious complications in the long term.

20 Oct 2010

FDA approves Boehringer Ingelheim's Pradaxa for stroke risk reduction in patients with non-valvular AF

The US Food and Drug Administration (FDA) has approved Pradaxa® (dabigatran etexilate), Boehringer Ingelheim's novel, oral direct thrombin inhibitor for stroke risk reduction in patients with non-valvular atrial fibrillation (AF) marking the first approval of a new oral anticoagulant in the U.S. in more than 50 years.

20 Oct 2010

Aspirin before cardiac surgery reduces postoperative cardiocerebral complications

A study presented at the American Society of Anesthesiologists 2010 Annual Meeting revealed that use of aspirin before cardiac surgery reduced postoperative cardiocerebral complications, including stroke, myocardial ischemia, heart block and cardiac arrest by more than 33 percent when compared to patients who did not use aspirin.

20 Oct 2010

Smokers have more complications and higher death rate after surgery than non-smokers

Results from a clinical study presented at ANESTHESIOLOGY 2010 found that smokers have significantly more complications post-surgery than non-smokers, including a higher death rate.

20 Oct 2010

Preoperative statin therapy prior to coronary bypass surgery improves survival rate

Findings from a study presented at this year's American Society of Anesthesiologists Annual Meeting reveal that patients who undergo preoperative statin therapy prior to coronary bypass surgery have a better survival rate.

20 Oct 2010

Beryl Institute awards $1,000 grants to health care organizations

As part of its commitment to supporting efforts to improve the patient experience in healthcare, The Beryl Institute has awarded $1,000 grants to ten health care organizations that are exploring effective methods for addressing patient experience issues.

20 Oct 2010

Vitro signs contract with HemoGenix to manufacture, distribute stem cell analysis tools

Vitro Diagnostics, Inc., dba Vitro Biopharma, announced that it signed an amendment to its contract to jointly manufacture and distribute stem cell analysis tools with HemoGenix, Inc., a leading firm known for its pioneering HALO analysis platform for stem cells.

20 Oct 2010

Heart Disease News and Research

Latest Heart Disease News and Research

Genzyme third quarter revenue increases to $1.0 billion

Beaumont Hospital announces opening of new Ernst Cardiovascular Center

Z-Medica enters agreement with two Swedish medical device distributors for QuikClot products

Alexion announces results of eculizumab two open-label Phase 2 studies for aHUS treatment

Genzyme reports results of Clolar combination Phase 3 trial in adult AML

FDA approves Herceptin with chemotherapy for HER2-positive metastatic cancer

NHS needs £20bn of efficiency savings

Abbott third quarter worldwide sales increase 11.8% to $8.7 billion

Pfizer enters partnership with Teuto to develop, commercialize generic medicines

St. Jude Medical third quarter net sales increase 7% to $1.240 billion

CRN reinforces importance of DHA before, during and after pregnancy

ACS NSQIP recognizes Christiana Care Health System as participating hospital

PBS-Bio announces three new contracts to develop cancer therapy

Study finds massive blood transfusion associated with severe complications

FDA approves Boehringer Ingelheim's Pradaxa for stroke risk reduction in patients with non-valvular AF

Aspirin before cardiac surgery reduces postoperative cardiocerebral complications

Smokers have more complications and higher death rate after surgery than non-smokers

Preoperative statin therapy prior to coronary bypass surgery improves survival rate

Beryl Institute awards $1,000 grants to health care organizations

Vitro signs contract with HemoGenix to manufacture, distribute stem cell analysis tools

Unlocking drug amorphization: Continuous, solvent-free twin screw granulation

How can super-resolution technology help study neurotransmission?

The Proteoform Puzzle: Unlocking the Next Frontier

Heart Disease News and Research

Latest Heart Disease News and Research

Unlocking drug amorphization: Continuous, solvent-free twin screw granulation

How can super-resolution technology help study neurotransmission?

The Proteoform Puzzle: Unlocking the Next Frontier

Newsletters you may be interested in